Author

Matthieu Allez

IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19
IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY

Matthieu Allez  et al.

IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19
IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19

Matthieu Allez  et al.

IL-23p19 inhibitors
IL-23p19 inhibitors

Matthieu Allez

Fertility impairment: Medical vs surgical view
Fertility impairment: Medical vs surgical view

Matthieu Allez

COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE
COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE

Matthieu Allez  et al.

How to manage postoperative recurrence?
How to manage postoperative recurrence?

Matthieu Allez

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY

Early identification of colon cancer: How to do it best?
Early identification of colon cancer: How to do it best?

Matthieu Allez

Which clinical targets have the potential to change the natural course of IBD? (Takeda)
Which clinical targets have the potential to change the natural course of IBD? (Takeda)

Matthieu Allez  et al.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Matthieu Allez  et al.

IMPACT OF BIOLOGICS ON THE RISK OF EARLY POSTOPERATIVE COMPLICATIONS IN CROHN'S DISEASE: A FRENCH NATIONWIDE STUDY
IMPACT OF BIOLOGICS ON THE RISK OF EARLY POSTOPERATIVE COMPLICATIONS IN CROHN'S DISEASE: A FRENCH NATIONWIDE STUDY

Matthieu Allez  et al.

VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE
VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE

Matthieu Allez  et al.

MICROBIAL SIGNALS AND HOST SENSING CONTROL METABOLIC INJURY IN THE INTESTINAL EPITHELIUM
MICROBIAL SIGNALS AND HOST SENSING CONTROL METABOLIC INJURY IN THE INTESTINAL EPITHELIUM

Matthieu Allez  et al.

SEVERE GASTRITIS AND DUODENITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A MULTICENTER STUDY
SEVERE GASTRITIS AND DUODENITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A MULTICENTER STUDY

Matthieu Allez  et al.

METABOLIC INJURY OF THE INTESTINAL EPITHELIUM TRIGGERS DYSBIOTIC EXPANSION OF BACTEROIDES SPP. DRIVING CHRONIC INFLAMMATION
METABOLIC INJURY OF THE INTESTINAL EPITHELIUM TRIGGERS DYSBIOTIC EXPANSION OF BACTEROIDES SPP. DRIVING CHRONIC INFLAMMATION

Matthieu Allez  et al.

COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

Matthieu Allez  et al.

LONGITUDINAL DYNAMICS OF GUT MICROBIOME AND METABOLOME AFTER BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASES
LONGITUDINAL DYNAMICS OF GUT MICROBIOME AND METABOLOME AFTER BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASES

Matthieu Allez  et al.

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

Matthieu Allez  et al.

INFLIXIMAB PLUS AZATHIOPRINE AND QUICK STEROIDS DISCONTINUATION VERSUS AZATHIOPRINE PLUS STEROIDS IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS STEROIDS: A PARALLEL, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL
INFLIXIMAB PLUS AZATHIOPRINE AND QUICK STEROIDS DISCONTINUATION VERSUS AZATHIOPRINE PLUS STEROIDS IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS STEROIDS: A PARALLEL, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL

Matthieu Allez  et al.

Item 1 - 20 / 23
1
2